Total Funding
22
Total FundingSeed raised
Growth Score
pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Harbor Therapeutics develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health.
Christopher L. Reading: Chief Scientific Officer
About the Company
Harbor Therapeutics, Inc. is the world leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals and potential nutraceuticals for human health. The adrenals, triangular glands located above each kidney, produce among other key components of the human metabolome, dozens of steroid hormones and have yielded
some of the most successful pharmaceuticals.
